Eventide Asset Management - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 47 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$882,000
+51.0%
384,0000.0%0.02%0.0%
Q1 2020$584,000
-37.9%
384,000
-20.5%
0.02%
-29.6%
Q4 2019$941,000483,0000.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,370,000$17,732,7001.93%
CSS LLC/IL 8,157,000$13,813,8470.86%
Worth Venture Partners, LLC 917,000$1,562,0520.85%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,198,000$8,887,1870.19%
BOOTHBAY FUND MANAGEMENT, LLC 2,495,000$4,354,5550.10%
Point72 Asset Management, L.P. 9,007,000$15,327,3320.05%
PALISADE CAPITAL MANAGEMENT, LP 1,000,000$1,696,2500.04%
CAPSTONE INVESTMENT ADVISORS, LLC 5,082,000$8,580,1430.04%
SSI INVESTMENT MANAGEMENT LLC 141,000$237,7030.02%
LORD, ABBETT & CO. LLC 3,005,000$5,0660.02%
View complete list of SAREPTA THERAPEUTICS INC shareholders